Chandigarh: A study of Covid complications in children revealed that they have hepatitis too.
The inflammatory system Syndrome (MISC) is the most common post-covid presentation in it but this study saw liver disease in post-covid children who had never had existing cases before.
Institute of Education and Medical Research Postgraduate (PGimer) conducted this study together with the medical center in Madhya Pradesh.
The authors, Doctors Sumit Kumar took care, Ajit Anand Asati, Ashish Jain, and R K Ratho, have published their jobs in Prefrint.
As a retrospective observational study and follow-up from April 2021 to mid-June 2021, they reviewed all of their pediatric patients with acute hepatitis and observed a sudden increase in its features in the group during the second wave of Koronavirus infection, where “children or teenagers developed Suddenly acute hepatitis onset without a history of previous liver disease in the absence of acute acute etiology of acute hepatitis, a three-week history of recent RT-PCR, or Covid-19 infection which was proven retrospectively with a high titist antibody sars cov -2 “.
These patients have an asymptomatic covid-19 infection, while other very small groups have signs similar to MISC, which are identified with large presentations, involvement of many organs, and Covid-19.
Among 33 patients presented with hepatitis, 25 showed unique features related to hepatitis (CAHC).
These patients do not have a typical covid symptom.
They have a normal inflammatory marker on the limit, and by going to the general care ward, all recovered on supportive care without complications or mortality.
However, patients with MISC require acceptance to critical care.
They have high inflammatory markers and 3 (37.5%) of eight have adverse results.
The authors concluded that with the emergence of newer variants of concerns such as Delta (which caused a large wave of Covid-19 in India), CAHC was one of their presentations varied.
“This new entity needs to be identified on time and is distinguished from other types of hepatitis for appropriate management,” said the researchers mentioned in this study.
The age group of these children ranges from 4 months to 14 years.